Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs

PHASE4CompletedINTERVENTIONAL
Enrollment

1,565

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2022

Study Completion Date

June 30, 2023

Conditions
Bipolar Disorder
Interventions
DRUG

Metformin

Metformin - to achieves maximum insulin-sensitizing effects

BEHAVIORAL

healthy lifestyle intervention (LIFE)

Healthy Life style intervention

Trial Locations (29)

10029

Mount Sinai, New York

11004

Northwell Zucker Long Island Jewish Hospital, Glen Oaks

LIJ Zucker Hillside Hospital, New York

11203

SUNY Downstate/ Kings County Hospital, Brooklyn

11219

Maimonides, Brooklyn

11233

NYCCC, Brooklyn

11373

Child Center of New York,, Queens

11577

NorthShore Child and Family Guidance, Roslyn Heights

11701

South Oaks, Amityville

11794

StonyBrook, Stony Brook

41011

The Children's Home of Northern Kentucky, Covington

43205

Nationwide Children's Hospital Columbus, Columbus

43210

Ohio State University, Columbus

44106

University Hospital Medical Center Cleveland, Cleveland

45011

Butler Behavioral Health Services, Hamilton

45206

Lighthouse Youth Services, Cincinnati

45219

Central Clinic, Cincinnati

45227

Children's Home, Cincinnati

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

Resident Mood Medication Clinic, Cincinnati

45237

St. Aloysius, Cincinnati

45238

Talbert House, Cincinnati

45239

St. Joseph's Orphanage, Cincinnati

45244

Child Focus, Cincinnati

45246

NECCO, Cincinnati

45385

TCN Family Solutions, Xenia

78712

Seton Family of Hospitals, Austin

07753

Jersey Shore Medical Center, Neptune City

Unknown

South Community, Dayton

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

Melissa Delbello

OTHER

NCT02515773 - Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs | Biotech Hunter | Biotech Hunter